Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Joseph Walter

Pediatric Pulmonology Tulsa, OK Medical Doctor

NPI 1336109966 CMS profile 287376

6465 S Yale Ave Ste 910, Tulsa, OK 74136

Open in the dashboard

General payments

$6,780

416 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Joseph Walter of Tulsa, OK is reported in the CMS Open Payments database as having received $6,780 across 416 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Pediatric Pulmonology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $962 60
2024 General $709 35
2023 General $722 41
2022 General $991 66
2021 General $1,290 84
2020 General $1,034 61
2019 General $1,072 69

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joseph Walter
  • Pediatric Pulmonology median
  • Middle half of Pediatric Pulmonology
  • National median

In program year 2025, general payments to Joseph Walter were reported at $962. Among 622 Pediatric Pulmonology profiles paid that year, the median was $139 and the middle half received between $60 and $405.

Show as a table
Year Joseph Walter Pediatric Pulmonology median Middle half National median
2019 $1,072 $151 $59–$495 $163
2020 $1,034 $107 $34–$339 $114
2021 $1,290 $125 $40–$511 $132
2022 $991 $133 $49–$428 $149
2023 $722 $138 $44–$494 $160
2024 $709 $132 $46–$398 $164
2025 $962 $139 $60–$405 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $1,320 86 payments
  2. Baxter Healthcare $915 42 payments
  3. AstraZeneca Pharmaceuticals LP $769 43 payments
  4. Electromed, Inc. $733 57 payments
  5. Chiesi USA, Inc. $707 53 payments
  6. Philips Electronics North America Corporation $493 28 payments
  7. Advanced Respiratory, Inc $348 25 payments
  8. Gilead Sciences, Inc. $224 13 payments
  9. Mylan Specialty L.P. $155 9 payments
  10. Nestle HealthCare Nutrition Inc. $122 7 payments
  11. Other $994 53 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,638 391 payments
  2. Education $141 25 payments
Products named General payments · program years 2019–2025
  1. CREON $1,195 78 payments
  2. SMARTVEST $568 41 payments
  3. PERTZYE $514 34 payments
  4. Hillrom - Monarch Airway Clearance System $505 22 payments
  5. BEVESPI AEROSPHERE $442 24 payments
  6. BETHKIS $409 20 payments
  7. SYMBICORT $352 16 payments
  8. Hillrom - Vest System Model 105 Home Care $351 16 payments
  9. The Vest System Model 105 Home Care $270 21 payments
  10. BRONCHITOL $223 19 payments
  11. Other $2,669 151 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

416 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Pulmonology in Oklahoma

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record